Stephanie Trunk’s Insights

317 total results. Page 22 of 27.

Health Care Counsel Blog
FDA Issues Final Version of Guidance for Industry, Contract Manufacturing Arrangements for Drugs: Quality Agreements
Health Care Counsel Blog
FDA Announcement on Guidance for Industry, Generic Drug User Fee Amendments of 2012
Health Care Counsel Blog
CMS Publishes Covered Outpatient Drug Final Rule
Health Care Counsel Blog
Drug Manufacturers Participating in 340B Program Must Execute New Pricing Agreement Addendum
Health Care Counsel Blog
Mylan Agrees to $465 Million Settlement with DOJ Over EpiPen Medicaid Drug Rebate Reporting Classification
Health Care Counsel Blog
Is the Discount Safe Harbor No Longer ‘Safe?’
Alerts
Is the Discount Safe Harbor No Longer “Safe?”
News
Vermont Publishes First List of Pharmaceuticals for Transparency Reporting
Health Care Counsel Blog
Vermont Publishes First List of Pharmaceuticals for Transparency Reporting
Health Care Counsel Blog
New Dispute Resolution Process Finally Proposed for 340B Program
Health Care Counsel Blog
OCR’s HIPAA Guidance on Ransomware Expands Traditional Interpretation of ‘Breach’
Health Care Counsel Blog
Vermont the First State to Require Pricing Justification from Drug Manufacturers